Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2021 $ 1,316,759 $ 60 $ 1,793,431 $ (476,610) $ (122)
Common stock, beginning balance (in shares) at Dec. 31, 2021   604,174,329      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (62,319)     (62,319)  
Stock-based compensation 12,088   12,088    
Issuance of common stock upon exercise of stock options (in shares)   823,524      
Issuance of common stock upon exercise of stock options 428   428    
Issuance of common stock upon release of restricted stock units (in shares)   851,557      
Vesting of early exercised stock options and common stock issued in private placement 121   121    
Stock withheld related to net share settlement (in shares)   (13,041)      
Shares withheld related to net share settlement (85)   (85)    
Other comprehensive loss (2,558)       (2,558)
Common stock, ending balance (in shares) at Mar. 31, 2022   605,836,369      
Ending balance at Mar. 31, 2022 1,264,434 $ 60 1,805,983 (538,929) (2,680)
Beginning balance at Dec. 31, 2022 $ 1,164,741 $ 61 1,908,179 (734,653) (8,846)
Common stock, beginning balance (in shares) at Dec. 31, 2022 622,602,815 622,602,815      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (113,393)     (113,393)  
Stock-based compensation 14,157   14,157    
Issuance of common stock upon exercise of stock options (in shares)   945,803      
Issuance of common stock upon exercise of stock options 614   614    
Issuance of common stock upon release of restricted stock units (in shares)   5,836,813      
Vesting of early exercised stock options and common stock issued in private placement 104   104    
Issuance of common stock in private placement (in shares)   137,174      
Other comprehensive loss $ 3,272       3,272
Common stock, ending balance (in shares) at Mar. 31, 2023 629,522,605 629,522,605      
Ending balance at Mar. 31, 2023 $ 1,069,495 $ 61 $ 1,923,054 $ (848,046) $ (5,574)